The U.S. Food and Drug Administration has approved a groundbreaking new drug for advanced pancreatic cancer, giving patients a new treatment option for one of the deadliest forms of cancer. The FDA granted expedited approval on Wednesday to daraxonrasib, a first-of-its-kind daily pill designed to target mutated proteins that help pancreatic tumors grow. Revolution Medicines… Continue reading Pancreatic Cancer Drug: FDA Approves Landmark Treatment
Pancreatic Cancer Drug: FDA Approves Landmark Treatment